410 related articles for article (PubMed ID: 24818658)
1. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels.
Capasso R; Orlando P; Pagano E; Aveta T; Buono L; Borrelli F; Di Marzo V; Izzo AA
Br J Pharmacol; 2014 Sep; 171(17):4026-37. PubMed ID: 24818658
[TBL] [Abstract][Full Text] [Related]
2. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
Borrelli F; Romano B; Petrosino S; Pagano E; Capasso R; Coppola D; Battista G; Orlando P; Di Marzo V; Izzo AA
Br J Pharmacol; 2015 Jan; 172(1):142-58. PubMed ID: 25205418
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice.
Izzo AA; Capasso R; Aviello G; Borrelli F; Romano B; Piscitelli F; Gallo L; Capasso F; Orlando P; Di Marzo V
Br J Pharmacol; 2012 Jun; 166(4):1444-60. PubMed ID: 22300105
[TBL] [Abstract][Full Text] [Related]
4. Activation and desensitization of TRPV1 channels in sensory neurons by the PPARα agonist palmitoylethanolamide.
Ambrosino P; Soldovieri MV; Russo C; Taglialatela M
Br J Pharmacol; 2013 Mar; 168(6):1430-44. PubMed ID: 23083124
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice.
Capasso R; Izzo AA; Fezza F; Pinto A; Capasso F; Mascolo N; Di Marzo V
Br J Pharmacol; 2001 Nov; 134(5):945-50. PubMed ID: 11682441
[TBL] [Abstract][Full Text] [Related]
6. The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels.
Petrosino S; Schiano Moriello A; Cerrato S; Fusco M; Puigdemont A; De Petrocellis L; Di Marzo V
Br J Pharmacol; 2016 Apr; 173(7):1154-62. PubMed ID: 25598150
[TBL] [Abstract][Full Text] [Related]
7. Effects of palmitoylethanolamide on aqueous humor outflow.
Kumar A; Qiao Z; Kumar P; Song ZH
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4416-25. PubMed ID: 22589443
[TBL] [Abstract][Full Text] [Related]
8. N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism.
Okine BN; Madasu MK; McGowan F; Prendergast C; Gaspar JC; Harhen B; Roche M; Finn DP
Pain; 2016 Dec; 157(12):2687-2696. PubMed ID: 27649266
[TBL] [Abstract][Full Text] [Related]
9. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors.
Costa B; Comelli F; Bettoni I; Colleoni M; Giagnoni G
Pain; 2008 Oct; 139(3):541-550. PubMed ID: 18602217
[TBL] [Abstract][Full Text] [Related]
10. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
11. Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract.
Szymaszkiewicz A; Włodarczyk J; Wasilewski A; Di Marzo V; Storr M; Fichna J; Zielińska M
Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug; 393(8):1357-1364. PubMed ID: 32002574
[TBL] [Abstract][Full Text] [Related]
12. The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors.
Steiner AA; Molchanova AY; Dogan MD; Patel S; Pétervári E; Balaskó M; Wanner SP; Eales J; Oliveira DL; Gavva NR; Almeida MC; Székely M; Romanovsky AA
J Physiol; 2011 May; 589(Pt 9):2415-31. PubMed ID: 21486787
[TBL] [Abstract][Full Text] [Related]
13. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.
Ho WS; Barrett DA; Randall MD
Br J Pharmacol; 2008 Nov; 155(6):837-46. PubMed ID: 18695637
[TBL] [Abstract][Full Text] [Related]
14. The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoylethanolamide on intestinal transit in mice.
Cluny NL; Keenan CM; Lutz B; Piomelli D; Sharkey KA
Neurogastroenterol Motil; 2009 Apr; 21(4):420-9. PubMed ID: 19140957
[TBL] [Abstract][Full Text] [Related]
15. A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase.
Carey LM; Slivicki RA; Leishman E; Cornett B; Mackie K; Bradshaw H; Hohmann AG
Mol Pain; 2016; 12():. PubMed ID: 27178246
[TBL] [Abstract][Full Text] [Related]
16. A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator.
Manzo E; Schiano Moriello A; Tinto F; Verde R; Allarà M; De Petrocellis L; Pagano E; Izzo AA; Di Marzo V; Petrosino S
Cells; 2021 Feb; 10(2):. PubMed ID: 33672574
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids and endocannabinoid-like compounds modulate hypoxia-induced permeability in CaCo-2 cells via CB
Karwad MA; Couch DG; Wright KL; Tufarelli C; Larvin M; Lund J; O'Sullivan SE
Biochem Pharmacol; 2019 Oct; 168():465-472. PubMed ID: 31325449
[TBL] [Abstract][Full Text] [Related]
18. Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo-A Randomized, Placebo-controlled, Double-blind Controlled Trial.
Couch DG; Cook H; Ortori C; Barrett D; Lund JN; O'Sullivan SE
Inflamm Bowel Dis; 2019 May; 25(6):1006-1018. PubMed ID: 31054246
[TBL] [Abstract][Full Text] [Related]
19. Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy.
Citraro R; Russo E; Scicchitano F; van Rijn CM; Cosco D; Avagliano C; Russo R; D'Agostino G; Petrosino S; Guida F; Gatta L; van Luijtelaar G; Maione S; Di Marzo V; Calignano A; De Sarro G
Neuropharmacology; 2013 Jun; 69():115-26. PubMed ID: 23206503
[TBL] [Abstract][Full Text] [Related]
20. Full inhibition of spinal FAAH leads to TRPV1-mediated analgesic effects in neuropathic rats and possible lipoxygenase-mediated remodeling of anandamide metabolism.
Starowicz K; Makuch W; Korostynski M; Malek N; Slezak M; Zychowska M; Petrosino S; De Petrocellis L; Cristino L; Przewlocka B; Di Marzo V
PLoS One; 2013; 8(4):e60040. PubMed ID: 23573230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
